BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1691387)

  • 1. V2-like receptors mediate cerebral blood flow increase following vasopressin administration in rats.
    Koźniewska E; Szczepańska-Sadowska E
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):579-85. PubMed ID: 1691387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence against participation of V2 receptors in the increase of cerebral blood flow during hypoxemia in the rat.
    Koźniewska E; Oseka M
    Prog Brain Res; 1992; 91():59-62. PubMed ID: 1410434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of V2 vasopressin agonist and antagonists on blood pressure regulation in normotensive (WKY) and spontaneously hypertensive (SHR) rats.
    Budzikowski A; Lon S; Paczwa P; Szczepanska-Sadowska E
    J Auton Nerv Syst; 1992 Jun; 39(2):87-95. PubMed ID: 1430797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V1- and V2-receptor contributions to ovine fetal renal and cardiovascular responses to vasopressin.
    Ervin MG; Ross MG; Leake RD; Fisher DA
    Am J Physiol; 1992 Apr; 262(4 Pt 2):R636-43. PubMed ID: 1566929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotension during vasopressin receptor blockade: role of V2 receptors and sympathetic nervous system.
    Brooks VL; Hatton DC
    Am J Physiol; 1991 Jun; 260(6 Pt 2):H1878-87. PubMed ID: 1829332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary vasoconstriction produced by vasopressin in anesthetized goats. Role of vasopressin V1 and V2 receptors and nitric oxide.
    Fernández N; García JL; García-Villalón AL; Monge L; Gómez B; Diéguez G
    Eur J Pharmacol; 1998 Jan; 342(2-3):225-33. PubMed ID: 9548390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors.
    Manning M; Misicka A; Olma A; Klis WA; Bankowski K; Nawrocka E; Kruszynski M; Kolodziejczyk A; Cheng LL; Seto J
    J Med Chem; 1987 Dec; 30(12):2245-52. PubMed ID: 2960812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of V2 receptor activity on the pressor response to vasopressin in the rat.
    Shimizu K; Schwartz J; McGrath BP
    Clin Exp Pharmacol Physiol; 1991 May; 18(5):349-52. PubMed ID: 1829666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of midazolam (a benzodiazepine) on cerebral perfusion and oxygenation in dogs.
    Yeh FC; Chang CL; Chen HI
    Proc Natl Sci Counc Repub China B; 1988 Jul; 12(3):174-9. PubMed ID: 3244814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of endothelium-derived nitric oxide on cerebral circulation during normoxia and hypoxia in the rat.
    Koźniewska E; Oseka M; Styś T
    J Cereb Blood Flow Metab; 1992 Mar; 12(2):311-7. PubMed ID: 1548305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relaxation of human isolated mesenteric arteries by vasopressin and desmopressin.
    Martínez MC; Vila JM; Aldasoro M; Medina P; Flor B; Lluch S
    Br J Pharmacol; 1994 Oct; 113(2):419-24. PubMed ID: 7834191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin stimulates phosphatidylinositol turnover and aldosterone synthesis in rat adrenal glomerulosa cells: comparison with angiotensin II.
    Woodcock EA; Mcleod JK; Johnston CI
    Endocrinology; 1986 Jun; 118(6):2432-6. PubMed ID: 2938936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of V1/V2-receptor antagonism on renal function and response to vasopressin in conscious dogs.
    Rose CE; Rose KY; Kinter LB
    Am J Physiol; 1991 Feb; 260(2 Pt 2):F273-82. PubMed ID: 1825453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between V1 and V2 effects in hemodynamic response to vasopressin in dogs.
    Liard JF
    Am J Physiol; 1990 Feb; 258(2 Pt 2):H482-9. PubMed ID: 2137987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin-induced antipyresis in the medial amygdaloid nucleus of conscious rats.
    Federico P; Veale WL; Pittman QJ
    Am J Physiol; 1992 May; 262(5 Pt 2):R901-8. PubMed ID: 1534208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation into the influence of vasopressin on perfusion of the cortex and papilla of the rat kidney.
    Huang CL; Davis G; Johns EJ
    Exp Physiol; 1991 May; 76(3):399-408. PubMed ID: 1831621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct cardiac effects of vasopressin: role of V1- and V2-vasopressinergic receptors.
    Walker BR; Childs ME; Adams EM
    Am J Physiol; 1988 Aug; 255(2 Pt 2):H261-5. PubMed ID: 2970231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thirst impairment elicited by intraventricular administration of vasopressin antagonists.
    Szczepanska-Sadowska E; Sobocinska J; Kozłowski S
    Peptides; 1987; 8(6):1003-9. PubMed ID: 2964590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors.
    Feng JJ; Arendshorst WJ
    Am J Physiol; 1996 Aug; 271(2 Pt 2):F304-13. PubMed ID: 8770161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.